Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:23
09/29/23
09/29
11:23
09/29/23
11:23
MDGL

Madrigal Pharmaceuticals

$151.92 /

+0.24 (+0.16%)

, AYTU

Aytu BioPharma

$2.70 /

-0.02 (-0.74%)

, FBIO

Fortress Biotech

/

+

, ADPT

Adaptive Biotechnologies

$5.60 /

+0.045 (+0.81%)

, AKRO

Akero Therapeutics

$48.91 /

+0.65 (+1.35%)

, SRPT

Sarepta

$122.67 /

-0.97 (-0.78%)

, ARAV

Aravive

/

+

, SGEN

Seagen

$212.40 /

+0.14 (+0.07%)

, BCLI

BrainStorm

/

+

, VKTX

Viking Therapeutics

$11.21 /

+0.005 (+0.04%)

These names in the…

Open Full Text

Recommendations
Regeneron price target raised to $680 from $665 at BofA » 06:55
09/29/23
09/29
06:55
09/29/23
06:55
REGN

Regeneron

$834.62 /

+2.545 (+0.31%)

, RHHBY

Roche

$33.95 /

-0.25 (-0.73%)

BofA raised the…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Wednesday
Hot Stocks
Ionis and Roche announce agreement for two RNA investigation programs » 07:03
09/27/23
09/27
07:03
09/27/23
07:03
IONS

Ionis Pharmaceuticals

$46.31 /

+3.625 (+8.49%)

, RHHBY

Roche

$34.03 /

-0.13 (-0.38%)

Ionis Pharmaceuticals…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Tuesday
Recommendations
Sarepta selloff yesterday a buying opportunity, says Mizuho » 06:42
09/26/23
09/26
06:42
09/26/23
06:42
SRPT

Sarepta

$114.75 /

-5.095 (-4.25%)

Mizuho analyst Uy Ear…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Monday
Recommendations
Roche price target lowered to CHF 290 from CHF 305 at Morgan Stanley » 14:02
09/25/23
09/25
14:02
09/25/23
14:02
RHHBY

Roche

$34.27 /

-0.25 (-0.72%)

Morgan Stanley lowered…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Over a week ago
Recommendations
Roche price target lowered to $40 from $45 at TD Cowen » 07:35
09/12/23
09/12
07:35
09/12/23
07:35
RHHBY

Roche

$35.49 /

-0.35 (-0.98%)

TD Cowen analyst Steve…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Recommendations
Roche price target lowered to $40 from $45 at TD Cowen » 07:32
09/12/23
09/12
07:32
09/12/23
07:32
RHHBY

Roche

$35.49 /

-0.35 (-0.98%)

TD Cowen lowered the…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Recommendations
Roche price target lowered to $41 from $45 at TD Cowen » 07:25
09/12/23
09/12
07:25
09/12/23
07:25
RHHBY

Roche

$35.49 /

-0.35 (-0.98%)

TD Cowen analyst Steve…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Halozyme informed by Roche of delay in projected Tecentriq SC launch in U.S. » 07:17
09/08/23
09/08
07:17
09/08/23
07:17
HALO

Halozyme

$39.13 /

-1.88 (-4.58%)

, RHHBY

Roche

$35.80 /

+0.42 (+1.19%)

In a regulatory filing…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Roche, Alnylam report Phase 2 KARDIA-1 study of zilebesiran met primary endpoint » 07:22
09/07/23
09/07
07:22
09/07/23
07:22
RHHBY

Roche

$35.38 /

-0.11 (-0.31%)

, ALNY

Alnylam

$201.51 /

+1.08 (+0.54%)

Roche (RHHBY) and Alnylam…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.